According to Harmony Biosciences's latest financial reports the company's current EPS (TTM) is $2.52. In 2022 the company made an earnings per share (EPS) of $3.06 an increase over its 2021 EPS that were of $0.60.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $2.52 | -17.65% |
2022 | $3.06 | 410% |
2021 | $0.60 | -150.1% |
2020 | -$1.20 | -64.64% |
2019 | -$3.39 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.27 | -110.71% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$1.00 | -139.68% | ๐บ๐ธ USA |